About The Hutch
At Fred Hutch, our interdisciplinary teams of world-renowned scientists and humanitarians work together to prevent, diagnose and treat cancer, HIV/AIDS and other diseases. Our researchers — including three Nobel laureates — bring a relentless passion to their work and deliver hope to patients who come here from all over the world.
We’re discovering new ways to detect cancers earlier, when cure rates are highest; developing effective treatments with fewer side effects; and learning how to prevent cancers from developing in the first place.
In April 2022, Fred Hutchinson Cancer Research Center, Seattle Cancer Care Alliance (SCCA) and UW Medicine completed the restructure of their longtime relationship and the formation of Fred Hutchinson Cancer Center, an independent, private, nonprofit organization focused on adult oncology research and care. Fred Hutchinson Cancer Center brings together Fred Hutchinson Cancer Research Center and SCCA into a unified adult cancer and research center that is a clinically integrated part of UW Medicine and is UW Medicine’s cancer program.
Pioneers in Transplantation and Immunotherapy
Our Nobel Prize–winning work on bone marrow transplantation provided the first example of the power of the human immune system to cure cancer. Today, we continue to lead this revolutionary field, known as immunotherapy.
Fred and Bill Hutchinson
When the doors of his cancer research center opened in 1975, Seattle surgeon Bill Hutchinson named it for his brother, baseball legend Fred Hutchinson. A major-league pitcher, Fred had died of cancer in 1964 at age 45.
Nobel Laureates
Three Nobel laureates have made their prize-winning discoveries under the auspices of Fred Hutch. We’re honored to count among our ranks Drs. Linda Buck, Lee Hartwell and E. Donnall Thomas. (Thomas died in 2012 at the age of 92.)
Our Global Reach
Seattle Campus
Our scientists work in some of the world’s finest research facilities, which were designed to promote cross-disciplinary collaboration. Located in the heart of Seattle’s tech hub in the South Lake Union neighborhood, our beautiful waterfront campus welcomes all visitors.
Cape Town Lab
Our Cape Town lab is one of the most advanced research facilities in South Africa. Opened in 2013, the 10,000-square-foot space is helping to accelerate HIV-vaccine development efforts via the Fred Hutch–led HIV Vaccine Trials Network. With Table Mountain as their backdrop, researchers analyze blood samples from clinical trial participants and study how their immune systems interact with both vaccine and virus. The lab also trains South African scientists in techniques to diagnose HIV and AIDS. Initially staffed with fewer than a dozen people, the lab is growing as clinical trials expand to involve some 12,000 participants.
UCI-Fred Hutch Cancer Centre
In partnership with the Uganda Cancer Institute, we’ve built the UCI-Fred Hutch Cancer Centre in Kampala: a world-class facility for research, training and patient care. Together, we created a state-of-the-art center where we research the biology of infection-related cancers with the goal of improving prevention and treatment. This is also where the country’s next generation of oncologists will train. The UCI/Hutchinson Center Cancer Alliance unites our expertise in leading large studies of cancer and infectious diseases with the UCI's long history of achievement, including the first description of infection-related cancer and the first use of combination chemotherapy for cancer treatment.
China
Fred Hutch has been collaborating with Chinese medical researchers for decades. The country’s large population, located in highly developed urban centers as well as lower-resource rural areas, together with its growing investment in biomedical research provide unique opportunities to gain insight into a variety of health issues that affect millions in China and around the world. Global Oncology China is an opportunity to make a worldwide impact. We are sharing scientific data, statistical analysis methods, clinical research protocol development and operation, and cross training of our scientific staff.
Our Priorities
Achieving our mission requires both careful planning and bold creativity, as well as equal measures of focus and flexibility to follow the science wherever it leads. Through our center-wide strategic planning process, we have identified the following research priorities:
Blood Stem Cell Transplantation
and Immunotherapy
Cancer Risk Factors, and Causes, Prevention and Outcomes
Vaccine Development
and Virus-Associated Cancers
Molecular Underpinnings of Cancer